Epstein-Barr virus antibodies can distinguish MS from other neuroinflammatory diseases

The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this week in JAMA Neurology by a team of international researchers, including one from the University at Buffalo. Bianca Weinstock-Guttman, MD, SUNY Distinguished Professor in the Department of Neurology at the Jacobs School of Medicine and Biomedical Sciences at UB, a leading international expert on MS and the director of the New York State MS Consortium, is one of the co-authors of the paper titled "Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases."